More tools:Markets·Screener·Research Chat

CVS HEALTH CORPORATION (CVS) Financial Statements

CVS HEALTH CORPORATION
SIC 5912 · RETAIL-DRUG STORES AND PROPRIETARY STORES
FIGI BBG001S5QBD8
XNYS · usd
106.18▲ 0.28 (0.26%)
As of 2026-07-14
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)$407.9B
Net Income (TTM)$2.9B
EBITDA
Diluted EPS (TTM)
EBITDA Margin2.6%
Net Debt
Trading Information
Previous Close105.90
Day's Range105.10 – 106.93
52-Week Range58.50 – 106.93
Volume9.06M
Avg Volume7.81M
Share Statistics
Shares Outstanding1.3B
Employees300.0K
ExchangeXNYS
Listed1952-10-01

Key questions about CVS HEALTH CORPORATION (CVS)

What is CVS HEALTH CORPORATION's Market Cap?
CVS HEALTH CORPORATION's Market Cap is $135.5B, based on as-reported figures from SEC (XBRL) filings.
What is CVS HEALTH CORPORATION's Enterprise Value?
CVS HEALTH CORPORATION's Enterprise Value is $189.1B, based on as-reported figures from SEC (XBRL) filings.
What is CVS HEALTH CORPORATION's Trailing P/E?
CVS HEALTH CORPORATION's Trailing P/E is 46.2×, based on as-reported figures from SEC (XBRL) filings.
What is CVS HEALTH CORPORATION's Price / Sales?
CVS HEALTH CORPORATION's Price / Sales is 0.3×, based on as-reported figures from SEC (XBRL) filings.
What is CVS HEALTH CORPORATION's EV / Revenue?
CVS HEALTH CORPORATION's EV / Revenue is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is CVS HEALTH CORPORATION's EV / EBITDA?
CVS HEALTH CORPORATION's EV / EBITDA is 18.0×, based on as-reported figures from SEC (XBRL) filings.
What is CVS HEALTH CORPORATION's Revenue (TTM)?
CVS HEALTH CORPORATION's Revenue (TTM) is $407.9B, based on as-reported figures from SEC (XBRL) filings.
What is CVS HEALTH CORPORATION's Net Income (TTM)?
CVS HEALTH CORPORATION's Net Income (TTM) is $2.9B, based on as-reported figures from SEC (XBRL) filings.
What is CVS HEALTH CORPORATION's EBITDA?
CVS HEALTH CORPORATION's EBITDA is $10.5B, based on as-reported figures from SEC (XBRL) filings.
What is CVS HEALTH CORPORATION's Diluted EPS (TTM)?
CVS HEALTH CORPORATION's Diluted EPS (TTM) is 2.30, based on as-reported figures from SEC (XBRL) filings.
Loading Income Statement…
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
Revenues:
Products
Premiums
Services
Net investment income
Total revenues
YoY growth+6.2%+8.2%+7.8%+8.4%
Operating costs:
Cost of products sold
Health care costs
Operating expenses
Total operating costs
% of revenue95.3%98.0%103.1%97.6%
Income (loss) from operations
% of revenue4.7%2.0%-3.1%2.4%
Interest expense
Other income
Income (loss) before income taxes
Income tax expense (benefit)
Net income
% of revenue2.9%2.8%-3.9%1.0%
Net income attributable to noncontrolling interests
Net income attributable to CVS Health
% of revenue2.9%2.8%-3.9%1.0%
Net income per share attributable to CVS Health:
Basic
Diluted
Weighted average shares outstanding:
Basic
Diluted